Patents by Inventor Maureen Andrew

Maureen Andrew has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of coating a device using anti-thrombin heparin
    Patent number: 7045585
    Abstract: Novel conjugates of glycosaminoglycans, particularly heparin and dermatan sulfate, and amine containing species and therapeutic uses thereof are described. In particular, mild methods of conjugating heparins to proteins, such as antithrombin III and heparin cofactor II, which provide covalent conjugates which retain maximal biological activity are described. Uses of these conjugates to prevent thrombogenesis, in particular in lung airways, such as found in infant and adult respiratory distress syndrome, and on surfaces in contact with blood are also described.
    Type: Grant
    Filed: March 20, 2002
    Date of Patent: May 16, 2006
    Assignee: Hamilton Civic Hospital Research Development Inc.
    Inventors: Leslie Roy Berry, Hugh O'Brodovich, legal representative, Anthony Kam Chuen Chan, Maureen Andrew, deceased
  • Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
    Publication number: 20030124705
    Abstract: Novel conjugates of glycosaminoglycans, particularly heparin and dermatan sulfate, and amine containing species and therapeutic uses thereof are described. In particular, mild methods of conjugating heparins to proteins, such as antithrombin III and heparin cofactor II, which provide covalent conjugates which retain maximal biological activity are described. Uses of these conjugates to prevent thrombogenesis, in particular in lung airways, such as found in infant and adult respiratory distress syndrome, and on surfaces in contact with blood are also described.
    Type: Application
    Filed: March 20, 2002
    Publication date: July 3, 2003
    Inventors: Leslie Roy Berry, Maureen Andrew, Anthony Kam Chuen Chan
  • Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
    Publication number: 20030113314
    Abstract: Novel conjugates of glycosaminoglycans, particularly heparin and dermatan sulfate, and amine containing species and therapeutic uses thereof are described. In particular, mild methods of conjugating heparins to proteins, such as antithrombin III and heparin cofactor II, which provide covalent conjugates which retain maximal biological activity are described. Uses of these conjugates to prevent thrombogenesis, in particular in lung airways, such as found in infant and adult respiratory distress syndrome, and on surfaces in contact with blood are also described.
    Type: Application
    Filed: October 10, 2002
    Publication date: June 19, 2003
    Applicant: Hamilton Civic Hospitals Res Dev., Inc.
    Inventors: Leslie Berry, Maureen Andrew
  • Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
    Publication number: 20030100487
    Abstract: Novel conjugates of glycosaminoglycans, particularly heparin and dermatan sulfate, and amine containing species and therapeutic uses thereof are described. In particular, mild methods of conjugating heparins to proteins, such as antithrombin III and heparin cofactor II, which provide covalent conjugates which retain maximal biological activity are described. Uses of these conjugates to prevent thrombogenesis, in particular in lung airways, such as found in infant and adult respiratory distress syndrome are also described.
    Type: Application
    Filed: October 11, 2002
    Publication date: May 29, 2003
    Applicant: Hamilton Civic Hospitals Res Dev., Inc.
    Inventors: Leslie Berry, Maureen Andrew
  • Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
    Patent number: 6562781
    Abstract: Novel conjugates of glycosaminoglycans, particularly heparin and dermatan sulfate, and amine containing species and therapeutic uses thereof are described. In particular, mild methods of conjugating heparins to proteins, such as antithrombin III and heparin cofactor II, which provide covalent conjugates which retain maximal biological activity are described. Uses of these conjugates to prevent thrombogenesis, in particular in lung airways, such as found in infant and adult respiratory distress syndrome are also described.
    Type: Grant
    Filed: November 30, 1995
    Date of Patent: May 13, 2003
    Assignee: Hamilton Civic Hospitals Research Development Inc.
    Inventors: Leslie Berry, Maureen Andrew
  • Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
    Patent number: 6491965
    Abstract: Novel conjugates of glycosaminoglycans, particularly heparin and dermatan sulfate, and amine containing species and therapeutic uses thereof are described. In particular, mild methods of conjugating heparins to proteins, such as antithrombin III and heparin cofactor II, which provide covalent conjugates which retain maximal biological activity are described. Uses of these conjugates to prevent thrombogenesis, in particular in lung airways, such as found in infant and adult respiratory distress syndrome, and on surfaces in contact with blood are also described.
    Type: Grant
    Filed: December 17, 1996
    Date of Patent: December 10, 2002
    Assignee: Hamilton Civic Hospitals Research Development, Inc.
    Inventors: Leslie Berry, Maureen Andrew